CM did not alter the mRNA expression of key steroidogenic metabolizing enzymes in the testis and prostate except testicular Srd5a1 in a BPH model, indicating that CM did not alter the conversion of testosterone to DHT by increasing the expression of metabolic enzymes. The gene discussed is SRD5A1; the disease is benign prostatic hyperplasia.